FdaApplication

NDA 212801

Back to search

Identifiers

Properties

PropertyValue
applicant_nameRECORDATI RARE DISEASES INC
application_typeNDA
approval_date2020-03-06

Products (3)

ProductActive ingredientStrengthDosage form
ISTURISAOSILODROSTAT PHOSPHATEEQ 1MG BASETABLET;ORAL
ISTURISAOSILODROSTAT PHOSPHATEEQ 5MG BASETABLET;ORAL
ISTURISAOSILODROSTAT PHOSPHATEEQ 10MG BASETABLET;ORAL

3 products